Developing Next-Generation Immunostimulatory Dual Payload ADCs to Enhance Therapeutic Index & Tackle Patient Resistance 

• Exploring targeted delivery of cytotoxins and immune agonists simultaneously
• Explaining how dual mechanisms enable direct tumor cell killing and activation of anti-tumor immunity
• Demonstrating immunostimulatory ADC enhanced efficacy and therapeutic index